Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2002 1
2003 1
2004 1
2007 2
2008 3
2009 4
2010 3
2011 1
2012 2
2013 4
2014 5
2015 2
2016 5
2017 3
2018 6
2019 4
2020 4
2021 7
2022 7
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Lifestyle factors for the prevention of inflammatory bowel disease.
Lopes EW, Chan SSM, Song M, Ludvigsson JF, Håkansson N, Lochhead P, Clark A, Burke KE, Ananthakrishnan AN, Cross AJ, Palli D, Bergmann MM, Richter JM, Chan AT, Olén O, Wolk A, Khalili H; EPIC-IBD investigators. Lopes EW, et al. Gut. 2022 Dec 6:gutjnl-2022-328174. doi: 10.1136/gutjnl-2022-328174. Online ahead of print. Gut. 2022. PMID: 36591609
Acute Aortic Occlusion.
Grip O, Wanhainen A, Björck M. Grip O, et al. Circulation. 2019 Jan 8;139(2):292-294. doi: 10.1161/CIRCULATIONAHA.118.036420. Circulation. 2019. PMID: 30615512 No abstract available.
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D'Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel JF, Hertervig E; GETAID and the SPARE-Biocycle research group. Louis E, et al. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):215-227. doi: 10.1016/S2468-1253(22)00385-5. Epub 2023 Jan 11. Lancet Gastroenterol Hepatol. 2023. PMID: 36640794 Free PMC article. Clinical Trial.
Food Processing and Risk of Crohn's Disease and Ulcerative Colitis: A European Prospective Cohort Study.
Meyer A, Dong C, Casagrande C, Chan SSM, Huybrechts I, Nicolas G, Rauber F, Levy RB, Millett C, Oldenburg B, Weiderpass E, Heath AK, Tong TYN, Tjønneland A, Kyrø C, Kaaks R, Katzke VA, Bergman MM, Palli D, Masala G, Tumino R, Sacerdote C, Colorado-Yohar SM, Sánchez MJ, Grip O, Lindgren S, Luben R, Gunter MJ, Mahamat-Saleh Y, Boutron-Ruault MC, Carbonnel F. Meyer A, et al. Among authors: grip o. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1607-1616.e6. doi: 10.1016/j.cgh.2022.09.031. Epub 2022 Oct 12. Clin Gastroenterol Hepatol. 2023. PMID: 36243353
Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register.
Ludvigsson JF, Andersson M, Bengtsson J, Eberhardson M, Fagerberg UL, Grip O, Halfvarson J, Hjortswang H, Jäghult S, Karling P, Nordenvall C, Olén O, Olsson M, Rejler M, Strid H, Myrelid P. Ludvigsson JF, et al. Among authors: grip o. Scand J Gastroenterol. 2019 Sep;54(9):1089-1101. doi: 10.1080/00365521.2019.1660799. Epub 2019 Sep 9. Scand J Gastroenterol. 2019. PMID: 31498717 Free article. Review.
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.
Visuri I, Eriksson C, Karlqvist S, Lykiardopoulos B, Karlén P, Grip O, Söderman C, Almer S, Hertervig E, Marsal J, Malmgren C, Delin J, Strid H, Sjöberg M, Bergemalm D, Hjortswang H, Halfvarson J. Visuri I, et al. Among authors: grip o. Therap Adv Gastroenterol. 2023 May 30;16:17562848231174953. doi: 10.1177/17562848231174953. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37274297 Free PMC article.
67 results